Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-609-1 | CAS number: 7651-02-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Guinea pig maximisation test: not sensitising (OECD guideline 406; GLP); Induction: intradermal; Challenge: topical
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2008-09-09 to 2008-10-17
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A valid GPMT conducted according to guideline is available, which is reliable without restrictions and adequate for classification and labelling purposes. Potency estimation is not mandatory when existing guideline and GLP conforming data are available, which were conducted before the new annex of the REACH Regulation entered into force. Moreover, no indication for skin sensitisation was observed in this study, thus, no dose response information is needed. For this reason and for reasons of animal welfare no additional LLNA was conducted.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Species/strain: Hsd Poe: DH - guinea pigs (Full-Barrier)
- Source: Harlan Winkelmann GmbH, D.33178 Borchen
- Age at study initiation:
- Weight at study initiation: 300 - 361 g
- Housing: in groups in Terluran - cages on Altromin saw fiber bedding
- Diet (e.g. ad libitum): Altromin 3122 maintenance diet for guinea pigs, ad libitum
- Water (e.g. ad libitum): tap water (drinking water, municipal residue control, microbioI. controlled periodically), ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 °C
- Humidity (%): 55 +/- 10 %
- Air changes (per hr): at least 10 x /hour
- Photoperiod (hrs dark / hrs light): Artificial light, sequence being 12 hours light, 12 hours dark
- Route:
- intradermal and epicutaneous
- Vehicle:
- paraffin oil
- Concentration / amount:
- Intradermal induction: 2.5 % of the test item, in paraffinum perliquidum
Dermal induction: 1 % of the test item, in paraffinum perliquidum
Challenge: 2 % of the test item, in paraffinum perliquidum - Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- Intradermal induction: 2.5 % of the test item, in paraffinum perliquidum
Dermal induction: 1 % of the test item, in paraffinum perliquidum
Challenge: 2 % of the test item, in paraffinum perliquidum - No. of animals per dose:
- Number of animals in the test group: 10
Number of animals in the negative control group: 5
Number of animals in the dose range finding study: 13 - Details on study design:
- RANGE FINDING TESTS:
Three animals were treated intradermally with a concentration of 2.5, 1.0, 0.5 % of the test item and the control vehicle (vehicle: paraffinum
perliquidum). Ten animals were treated topically with concentrations of 10, 5, 4, 3, 2.5, 2.0, 1, 1.5, 0.5, 0.1 % of the test item and the control
vehicle for 24 or 48 hours.
MAIN STUDY
A. INDUCTION EXPOSURE
Intradermal (day 0)
- No. of exposures: 3 pairs of intradermal injections of 0.1 mL
Test group:
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline
Injection 2: a 2.5 % concentration of the test item 1:1 paraffinum perliquidum
Injection 3: a 2.5 % concentration of the test item formulated in a 1:1 mixture (v/v) FCA/physiological saline
Control group:
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline
Injection 2: 100 % paraffinum perliquidum
Injection 3: a 50 % (v/v) formulation of paraffinum perliquidum in a 1:1 (v/v) mixture FCAIphysiological saline
Topical Application (day 7)
Test Group:
The test item was suspended in paraffinum perliquidum at a concentration of 1 %. A patch was fully loaded with 0.5 mL of the prepared test item,
applied to the test area and held in contact by an occlusive dressing for 48 hours.
Control Group:
A patch was fully loaded with 0.5 mL of the vehicle paraffinum perliquidum and applied to the test area and held in contact by an occlusive
dressing for 48 hours.
B. CHALLENGE EXPOSURE (day 20)
Test and Control Group:
The test item was suspended in paraffinum perliquidum at a concentration of 2 %. A patch, loaded with 0.5 mL of the prepared test item was applied
paraffinum perliquidum to the left flank of the animals and a patch loaded with 0.5 mL of the vehicle to the right flank (intraspecific control),
respectively. The patches were held in contact by an occlusive dressing for 24 hours.
The skin reaction was observed and recorded 24, 48 and 72 hours after patch removal.
OTHER:
Preparation of test item solution, example for a 1% solution:
1 g of the test item was weighed in a beaker and 99 g paraffinum perliquidum was added. A magnetic stirrer was put in the beaker and it was heated up to between 65°C and 75°C under agitation (approx. 400 rpm) on a heating plate. As soon as the test item was completely melted it was removed from the heating plate. A cloudy dispersion developed at room temperature. - Challenge controls:
- The test item was suspended in paraffinum perliquidum at a concentration of 2 %. A patch, loaded with 0.5 mL of the prepared test item was applied paraffinum perliquidum to the left flank of the animals and a patch loaded with 0.5 mL of the vehicle to the right flank (intraspecific control), respectively. The patches were held in contact by an occlusive dressing for 24 hours.
- Positive control substance(s):
- yes
- Remarks:
- Mercaptobenzothiazole, Purity > 98%. The recent reliability check was performed in April/May 2008, (BSL Project ID 081342).
- Positive control results:
- The Sensitisation rate after application of the positive control substance Mercaptobenzothiazole (15 % in Vaseline) was 70 %, confirming the
reliability of the test system. - Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 2 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 2 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 2 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 2 % . No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 2 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- no
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 2 % . No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 2 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- no
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 2 %. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: other: CLP, EU GHS (Regulation (EC) No 1272/2008)
- Conclusions:
- In this study, Stearic acid 3-(dimethylaminopropyl)amide (a.i. > 99 %), is not a dermal sensitiser.
- Executive summary:
In a dermal sensitisation study according to OECD TG 406, 1992) with Stearic acid 3-(dimethylaminopropyl)amide (a.i. > 99 %) in paraffinum perliquidum, young adult Dunkin-Hartley guinea pigs were tested using the Maximization test method. Positive control substance was mercaptobenzothiazole with a sensitisation rate of 70 %.
Mild to moderate skin reactions and necrosis were observed after intradermal induction (2.5 %) and dermal induction (1 %) in the test substance animals. After challenge exposure (2 %) no skin reactions were observed in test or control animals at any observation time. Therefore the sensitisation rate was 0 %.
For the challenge concentration, which is the highest non-irritant dose, 2 % of the test item was used. The higher challenge concentration compared to the dermal induction concentration can be explained by the different exposure times, i.e. 48 hours for the dermal induction and 24 hours for the challenge.
In this study, Stearic acid 3-(dimethylaminopropyl)amide (a.i. > 99 %), is not a dermal sensitiser.
Reference
Skin reaction after induction exposure:
Intradermal Induction (24hours reading):
Injection site 1: Erythema grade 1 in all control- and 7/10 test animals
Injection site 2: Erythema grade 1in 6/10 test animals; eschar in 2/10 test animals; necrosis in 5/10 test animals
Injection site 3: No signs of irritation were recorded for the control animals.
Erythema grade 1 in 1/5 control animals and in 7/10 test animals
Eschar in 2/10 test animals
Necrosis in 2/10 test animals
Intradermal Induction (48 hours reading):
Injection site1: Erythema grade 1in 7/10 test animals
Injection site2: Erythema grade 1in 5/10 test animals
Eschar in 3/10 test animals
Necrosis in 5/10 test animals
Oedema grade1in 1/10 test animals
Injection site 3: Erythema grade 1 in 6/1 0 test animals
Eschar in 3/10 test animals
Necrosis in 2/10 test animals.
Oedema grade 1 in 1/10 test animals
No signs of irritation were recorded for the control animals.
Dermal Induction (48 hours exposure, occlusive):
Immediately after removing the patch: Erythema grade 1 in 4/10 test animals
Erythema grade 2 in 6/10 test animals
Oedema grade 1 in 8/10 test animals
All animals showed necrosis.
24 hours after removing the patch: Erythema grade 1 in 8/10 test animals
Erythema grade 2 in 2/10 test animals
Oedema grade 1 in 8/10 test animals
All animals showed necrosis.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a dermal sensitisation study according to OECD TG 406, 1992) with Stearic acid 3-(dimethylaminopropyl)amide (a.i. > 99%) in paraffinum perliquidum, young adult Dunkin-Hartley guinea pigs were tested using the Maximization test method. Positive control substance was mercaptobenzothiazole with a sensitisation rate of 70%.
Mild to moderate skin reactions and necrosis were observed after intradermal induction (2.5%) and dermal induction (1%) in the test substance animals. After challenge exposure (2%) no skin reactions were observed in test or control animals at any observation time. Therefore the sensitisation rate was 0%.
For the challenge concentration, which is the highest non-irritant dose, 2% of the test item was used. The higher challenge concentration compared to the dermal induction concentration can be explained by the different exposure times, i.e. 48 hours for the dermal induction and 24 hours for the challenge.
In this study, Stearic acid 3-(dimethylaminopropyl)amide (a.i. > 99%), is not a dermal sensitiser.
This finding is supported by TOPKAT statistical model:
All validation criteria have been met by the assessment of the query. The performance of the submodel in the vicinity of the query is unknown. Therefore the Skin Sensitization NEG vs. SENS assessment as producing a negative response in the assay for the query structure is considered acceptable. Based on the prediction results obtained by means of TOPKAT statistical models system, the substance Stearic acid 3-(dimethylaminopropyl) amide is not a sensitiser. Computed probability was 0.0.
According to the Guidance on information requirements and chemical safety assessment, Chapter R.7a: “a probability of 0.7 or more indicates a strong sensitizer and a probability below 0.30 indicates a weak or moderate sensitizer. Probability values between 0.30 and 0.70 are referred to as indeterminate”.
There is no information available for respiratory sensitisation. Therefore, there is a data gap in this respect. However, the data gap cannot be fulfilled with experimental data, since there is no internationally accepted animal model for respiratory sensitisation. In case human data for respiratory sensitisation emerges, this will be taken into account. For skin sensitisation, there is no reason to believe that results obtained in guinea pigs would not be applicable to humans.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on relevant, reliable and adequate data, Stearic acid 3-(dimethylaminopropyl)amide does not have to be classified and labelled according to the CLP Regultion (EC) No 1272/2008 and Directive 67/548/EEC with respect to skin sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.